Many previous studies have reported that PIK3CA mutation status may be related to the prognosis of BC patients, but its predictive significance has remained controversial (Baselga et al. 2017; Di Leo et al. 2018; Loi, et al. 2013; Mosele, et al. 2020). This evidence concerns the gene PIK3CA and breast cancer.